Literature DB >> 69351

Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.

J Frick, G Bartsch, G Jakse.   

Abstract

Radioimmunoassays for 2 synthetic progestins (Ethinyl-norgestrienone, R 2323 and medroxyprogesterone acetate, MPA) are demonstrated. 10 patients aged 31 to 72 years were treated with ethinyl-norgestrienone with different schedules and 3 men suffering from benign prostatic hypertrophy were treated with medroxygesterone acetate. Plasma levels of testosterone, LH, FSH were monitored before, during and after treatment.

Entities:  

Keywords:  Androgens; Biology; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--analysis; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--analysis; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--analysis; Contraceptive Agents--side effects; Endocrine System; Examinations And Diagnoses; Family Planning; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hematological Effects; Hemic System; Hormones; Laboratory Examinations And Diagnoses; Laboratory Procedures; Luteinizing Hormone--analysis; Medroxyprogesterone Acetate--administraction and dosage; Medroxyprogesterone Acetate--analysis; Medroxyprogesterone Acetate--side effects; Men; Physiology; Research Methodology; Testosterone--analysis

Mesh:

Substances:

Year:  1977        PMID: 69351     DOI: 10.1007/BF00256842

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  8 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Long term effect of medroxyprogesterone acetate in human ovarian morphophysiology and sperm transport.

Authors:  J Zañartu; M Pupkin; D Rosenberg; A Davansens; R Guerrero; R Rodriguez-Bravo; M Garcia-Huidobro
Journal:  Fertil Steril       Date:  1970-07       Impact factor: 7.329

3.  GLC determination of medroxyprogesterone acetate in plasma.

Authors:  D G Kaiser; R G Carlson; K T Kirton
Journal:  J Pharm Sci       Date:  1974-03       Impact factor: 3.534

4.  Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma.

Authors:  L E Edqvist; E D Johansson
Journal:  Acta Endocrinol (Copenh)       Date:  1972-12

5.  Fluctuations in plasma testosterone levels in adult male rats and mice.

Authors:  A Bartke; R E Steele; N Musto; B V Caldwell
Journal:  Endocrinology       Date:  1973-04       Impact factor: 4.736

6.  A method of solid phase radioimmunoassay utilizing polypropylene discs.

Authors:  P G Crosignani; R M Nakamura; D N Hovland; D R Mishell
Journal:  J Clin Endocrinol Metab       Date:  1970-02       Impact factor: 5.958

7.  Measurement of medroxyprogesterone acetate (Provera ) by radioimmunoassay.

Authors:  J C Cornette; K T Kirton; G W Duncan
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

8.  Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera).

Authors:  K T Kirton; J C Cornette
Journal:  Contraception       Date:  1974-07       Impact factor: 3.375

  8 in total
  1 in total

Review 1.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.